Skip to content
PICO Portalanswers from OpenAlex

Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study

PaperCitations, authors & open-access status

Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study is a paper indexed in PICO Portal from OpenAlex.

How many citations does Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study have?

PICO Portalcitation count

Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study has 204 citations in the OpenAlex counts PICO Portal stores.

When was Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study published?

PICO Portalyear

Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study has 2020 year in the PICO Portal index.

What is the open-access status of Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study?

PICO Portaloa status

Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study has closed oa status in the PICO Portal index.

What is the DOI of Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study?

PICO Portaldoi

The DOI for Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study is on the source record.

What is the PMID of Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study?

PICO Portalpmid

The PMID for Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study is on the source record.

What is the OpenAlex record for Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study?

PICO Portalopenalex

The OpenAlex for Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial